These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35493453)

  • 41. Pediatric unmanipulated haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide and reduced intensity, TBI-free conditioning regimens in salvage transplantations.
    Wawrzyniak-Dzierżek E; Gajek K; Ślęzak A; Rybka B; Ryczan-Krawczyk R; Gorczyńska E; Kałwak K; Ussowicz M
    Adv Clin Exp Med; 2019 Sep; 28(9):1223-1228. PubMed ID: 31430069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of KIR/HLA Incompatibilities on NK Cell Reconstitution and Clinical Outcome after T Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation with Posttransplant Cyclophosphamide.
    Willem C; Makanga DR; Guillaume T; Maniangou B; Legrand N; Gagne K; Peterlin P; Garnier A; Béné MC; Cesbron A; Le Bourgeois A; Chevallier P; Retière C
    J Immunol; 2019 Apr; 202(7):2141-2152. PubMed ID: 30787107
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Post-Transplantation Cyclophosphamide and Ixazomib Combination Rescues Mice Subjected to Experimental Graft-versus-Host Disease and Is Superior to Either Agent Alone.
    Al-Homsi AS; Goodyke A; McLane M; Abdel-Mageed S; Cole K; Muilenburg M; Feng Y
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):255-261. PubMed ID: 27888016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Feasibility of HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for advanced pediatric malignancies.
    Sawada A; Shimizu M; Isaka K; Higuchi K; Mayumi A; Yoshimoto Y; Kikuchi H; Kondo O; Koyama-Sato M; Yasui M; Kawa K; Inoue M
    Pediatr Hematol Oncol; 2014 Nov; 31(8):754-64. PubMed ID: 25325678
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell Transplantation.
    Davies JK; Brennan LL; Wingard JR; Cogle CR; Kapoor N; Shah AJ; Dey BR; Spitzer TR; de Lima M; Cooper LJ; Thall PF; Champlin RE; Nadler LM; Guinan EC
    Clin Cancer Res; 2018 Sep; 24(17):4098-4109. PubMed ID: 29769208
    [No Abstract]   [Full Text] [Related]  

  • 46. Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
    Im A; Rashidi A; Wang T; Hemmer M; MacMillan ML; Pidala J; Jagasia M; Pavletic S; Majhail NS; Weisdorf D; Abdel-Azim H; Agrawal V; Al-Homsi AS; Aljurf M; Askar M; Auletta JJ; Bashey A; Beitinjaneh A; Bhatt VR; Byrne M; Cahn JY; Cairo M; Castillo P; Cerny J; Chhabra S; Choe H; Ciurea S; Daly A; Perez MAD; Farhadfar N; Gadalla SM; Gale R; Ganguly S; Gergis U; Hanna R; Hematti P; Herzig R; Hildebrandt GC; Lad DP; Lee C; Lehmann L; Lekakis L; Kamble RT; Kharfan-Dabaja MA; Khandelwal P; Martino R; Murthy HS; Nishihori T; O'Brien TA; Olsson RF; Patel SS; Perales MA; Prestidge T; Qayed M; Romee R; Schoemans H; Seo S; Sharma A; Solh M; Strair R; Teshima T; Urbano-Ispizua A; Van der Poel M; Vij R; Wagner JL; William B; Wirk B; Yared JA; Spellman SR; Arora M; Hamilton BK
    Biol Blood Marrow Transplant; 2020 Aug; 26(8):1459-1468. PubMed ID: 32434056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide.
    McCurdy SR; Kasamon YL; Kanakry CG; Bolaños-Meade J; Tsai HL; Showel MM; Kanakry JA; Symons HJ; Gojo I; Smith BD; Bettinotti MP; Matsui WH; Dezern AE; Huff CA; Borrello I; Pratz KW; Gladstone DE; Swinnen LJ; Brodsky RA; Levis MJ; Ambinder RF; Fuchs EJ; Rosner GL; Jones RJ; Luznik L
    Haematologica; 2017 Feb; 102(2):391-400. PubMed ID: 27846611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A preclinical acute GVHD mouse model based on chemotherapy conditioning and MHC-matched transplantation.
    Riesner K; Kalupa M; Shi Y; Elezkurtaj S; Penack O
    Bone Marrow Transplant; 2016 Mar; 51(3):410-7. PubMed ID: 26595081
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advances in haploidentical stem cell transplantation for hematologic malignancies.
    Montoro J; Sanz J; Sanz GF; Sanz MA
    Leuk Lymphoma; 2016 Aug; 57(8):1766-75. PubMed ID: 27424663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HLA-haploidentical stem cell transplantation using posttransplant cyclophosphamide.
    Sugita J
    Int J Hematol; 2019 Jul; 110(1):30-38. PubMed ID: 31104211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
    Sahebi F; Eikema DJ; Koster L; Kroger N; Meijer E; van Doesum JA; Rovira M; Koc Y; Angelucci E; Blaise D; Sammassimo S; McDonald A; Arroyo CH; Sanchez JF; Forcade E; Castagna L; Stölzel F; Sanz J; Tischer J; Ciceri F; Valcarcel D; Proia A; Hayden PJ; Beksac M; Yakoub-Agha I; Schönland S
    Transplant Cell Ther; 2021 Dec; 27(12):999.e1-999.e10. PubMed ID: 34543768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [HLA-haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide for adult T-cell leukemia].
    Ishii K; Okamoto S; Fujita M; Sugihara A; Nagaie T; Nishioka A; Kamachi K; Itamura H; Katsuya H; Yoshimura M; Ureshino H; Ando T; Kubota Y; Kimura S
    Rinsho Ketsueki; 2022; 63(5):333-340. PubMed ID: 35662154
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post-transplantation cyclophosphamide to facilitate HLA-haploidentical hematopoietic cell transplantation: Mechanisms and results.
    Elmariah H; Fuchs EJ
    Semin Hematol; 2019 Jul; 56(3):183-189. PubMed ID: 31202428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ruxolitinib is an effective salvage treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation without posttransplant cyclophosphamide.
    Zhao JY; Liu SN; Xu LP; Zhang XH; Wang Y; Chen YH; Liu KY; Huang XJ; Mo XD
    Ann Hematol; 2021 Jan; 100(1):169-180. PubMed ID: 33159239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation.
    Hanash AM; Levy RB
    Blood; 2005 Feb; 105(4):1828-36. PubMed ID: 15494429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunomagnetic selective donor-derived CD4
    Varlet P; Rogeau S; Trauet J; Demaret J; Labalette M
    Curr Res Transl Med; 2019 Feb; 67(1):1-7. PubMed ID: 30665880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications.
    Russo A; Oliveira G; Berglund S; Greco R; Gambacorta V; Cieri N; Toffalori C; Zito L; Lorentino F; Piemontese S; Morelli M; Giglio F; Assanelli A; Stanghellini MTL; Bonini C; Peccatori J; Ciceri F; Luznik L; Vago L
    Blood; 2018 Jan; 131(2):247-262. PubMed ID: 28986344
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Haploidentical Hematopoietic Cell Transplantation Using Post-transplant Cyclophosphamide for Children with Non-malignant Diseases.
    Hashem H; Najjar R; Abu-Shanap M; Khattab E; Rihani R; Tbakhi A; Sultan I
    J Clin Immunol; 2021 Nov; 41(8):1754-1761. PubMed ID: 34355352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opposing roles of interferon-gamma on CD4+ T cell-mediated graft-versus-host disease: effects of conditioning.
    Welniak LA; Blazar BR; Anver MR; Wiltrout RH; Murphy WJ
    Biol Blood Marrow Transplant; 2000; 6(6):604-12. PubMed ID: 11128810
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impacts of post-transplantation cyclophosphamide treatment after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
    Namdaroglu S; Kaya AH; Batgi H; Kayikci O; Dal MS; Iskender D; Kizil Cakar M; Tekgunduz E; Altuntas F
    Sci Rep; 2019 Feb; 9(1):2046. PubMed ID: 30765830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.